Platform technologies and human cell lines for the production of therapeutic exosomes
2021

Production of Therapeutic Exosomes

publication Evidence: moderate

Author Information

Author(s): Kim Jiyoon, Song Yonghee, Park Cheol Hyoung, Choi Chulhee

Primary Institution: ILIAS Biologics Inc.

Hypothesis

Customized strategies are needed to use appropriate technologies for exosome engineering and to select suitable production cell lines.

Conclusion

Exosomes derived from various human cells have shown potential as therapeutic agents, but further research is needed to optimize their production and efficacy.

Supporting Evidence

  • Exosomes can mediate the therapeutic effects of their parental cells.
  • Exosomes are important for intercellular communication.
  • Different cell types produce exosomes with varying biological properties.

Takeaway

Exosomes are tiny bubbles made by cells that can help deliver medicine and treat diseases. Scientists are figuring out the best ways to make and use them.

Methodology

This review discusses current platform technologies for developing therapeutic exosomes and the human cells/cell lines used for their production.

Limitations

The review highlights the need for more understanding of the pharmacological mechanisms of exosomes and their scalability for clinical applications.

Digital Object Identifier (DOI)

10.20517/evcna.2020.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication